According to Relay Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.91. In 2022 the company made an earnings per share (EPS) of -$2.60 an increase over its 2021 EPS that were of -$3.85.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.91 | 11.92% |
2022 | -$2.60 | -32.47% |
2021 | -$3.85 | -57.09% |
2020 | -$8.97 | -36.27% |
2019 | -$14.08 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -25.09% | ๐บ๐ธ USA |